PureTech Health (PRTC)

Sector:

Pharma and Biotech

Index:

FTSE 250

162.00p
   
  • Change Today:
      0.20p
  • 52 Week High: 237.50p
  • 52 Week Low: 140.40p
  • Currency: UK Pounds
  • Shares Issued: 239.42m
  • Volume: 496,505
  • Market Cap: £387.86m
  • Beta: 0.94

Dividend Data

  31-Dec-2331-Dec-2231-Dec-2131-Dec-2031-Dec-19
Total Dividendn/an/an/an/an/a
For more dividend details, click here

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
Revenue 3.33 15.62 17.39 11.77 9.81
Operating Profit/(Loss) (146.20) (197.81) (150.28) (119.53) (135.40)
Net Interest 5.08 138.92 5.05 (6.11) (46.15)
Profit Before Tax (36.10) (92.78) (58.95) 18.97 478.47
Profit After Tax (66.63) (37.06) (62.71) 4.57 366.07
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD (66.63) (37.06) (62.71) 4.57 366.07
Attributable to:          
Equity Holders of Parent Company (66.63) (37.06) (60.56) 5.99 421.14
Minority Interests (0.93) 13.29 (2.15) (1.42) (55.08)
           
Continuing EPS          
Earnings per Share - Basic (24.00¢) (18.00¢) (21.00¢) 2.00¢ 149.00¢
Earnings per Share - Diluted (24.00¢) (18.00¢) (21.00¢) 2.00¢ 144.00¢
Earnings per Share - Adjusted (24.00¢) (18.00¢) (21.00¢) 2.00¢ 149.00¢
Continuing and Discontinued EPS          
Earnings per Share - Basic (24.00¢) (18.00¢) (21.00¢) 2.00¢ 149.00¢
Earnings per Share - Diluted (24.00¢) (18.00¢) (21.00¢) 2.00¢ 144.00¢
Earnings per Share - Adjusted (24.00¢) (18.00¢) (21.00¢) 2.00¢ 149.00¢
           
Dividend per Share n/a n/a n/a n/a n/a
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Assets          
Non-Current Assets          
Property, Plant & Equipment 19.36 37.24 43.94 42.88 43.84
Intangible Assets 0.91 0.83 0.99 0.90 0.62
Investment Properties n/a n/a n/a n/a n/a
Investments 325.63 277.54 397.18 530.16 725.55
Other Financial Assets n/a n/a n/a n/a n/a
Other Non-Current Assets 0.88 0.85 2.09 1.71 2.32
  346.77 316.45 444.20 575.65 772.33
Current Assets          
Inventories n/a n/a n/a n/a n/a
Trade & Other Receivables 18.43 33.97 18.86 8.34 4.27
Cash at Bank & in Hand 191.08 149.87 465.71 403.88 132.36
Current Asset Investments 136.06 200.23 n/a n/a 30.09
Other Current Assets 1.63 2.12 17.24 2.12 2.12
  347.20 386.19 501.81 414.35 168.84
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 693.97 702.65 946.01 989.99 941.18
           
Liabilities          
Current Liabilities          
Borrowings 7.09 12.47 9.45 148.69 105.37
Other Current Liabilities 44.28 84.41 216.69 32.24 33.83
  51.37 96.88 226.13 180.92 139.20
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Non-Current Liabilities          
Borrowings 18.25 34.40 43.30 46.91 34.91
Provisions 52.46 19.65 89.76 108.62 115.44
Other Non-Current Liabilities 113.66 4.13 2.66 n/a 1.22
  184.37 58.17 135.72 155.53 151.58
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 235.74 155.06 361.86 336.45 290.78
           
Net Assets 458.23 547.59 584.15 653.54 650.40
           
Capital & Reserves          
Share Capital 5.46 5.45 5.44 5.42 5.41
Share Premium Account 290.26 289.62 289.30 288.98 287.96
Other Reserves 84.52 97.62 98.90 114.92 120.22
Retained Earnings 83.82 149.52 199.87 260.43 254.44
Shareholders Funds 464.07 542.22 593.52 669.75 668.04
           
Minority Interests/Other Equity (5.84) 5.37 (9.37) (16.21) (17.64)
Total Equity 458.23 547.59 584.15 653.54 650.40
Cash Flow 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Net Cash Flow From Operating Activities (105.92) (178.79) (158.27) (131.83) (98.16)
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a fn/a
Taxation Paid fn/a fn/a fn/a fn/a fn/a
Net Cash Flow from Investing Activities 68.99 (107.22) 197.38 364.48 63.66
Acquisitions & Disposals gn/a gn/a gn/a gn/a gn/a
Dividends Paid fn/a fn/a fn/a fn/a fn/a
Management of Liquid Resources cn/a cn/a cn/a cn/a cn/a
Net Cash Flow from Financing Activities 78.14 (29.83) 22.73 38.87 49.81
Net Increase/Decrease In Cash 41.22 (315.84) 61.83 271.52 15.31
Ratios - based on IFRS 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
PE Ratio - Adjusted n/a n/a n/a 251.8 2.7
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a -99% n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 1.21¢ 5.49¢ 0.061¢ 4.12¢ 3.46¢
Pre-Tax Profit per Share (13.07¢) (32.58¢) (0.21¢) 6.64¢ 168.82¢
Operating Margin (4,390.36%) (1,266.53%) (864.29%) (1,015.73%) (1,380.64%)
Return on Capital Employed n/a n/a n/a 2.62% 57.94%
Continuing & Discontinued Operations          
PE Ratio - Adjusted n/a n/a n/a 251.8 2.7
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a -99% n/a
Dividend Cover n/a n/a n/a n/a n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share (38.33¢) (62.79¢) (55.23¢) (46.16¢) (34.63¢)
Cash Incr/Decr per Share 14.92¢ (110.92¢) 0.22¢ 95.07¢ 5.40¢
Net Asset Value per Share (exc. Intangibles) 165.52¢ 192.01¢ 203.48¢ 228.51¢ 229.26¢
Net Gearing -35.71% -18.99% -69.58% -31.10% 1.19%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.

 

Top of Page